Kurs & Likviditet
Beskrivning
Land | Norge |
---|---|
Lista | OB Match |
Sektor | Hälsovård |
Industri | Bioteknik |
2021-06-03 22:50:00
Oslo, Norway, June 3, 2021 - Reference is made to the Annual General Meeting of
Vaccibody AS on May 5, 2021, where the issuance of Restricted Share Units (RSUs)
to the new board member Birgitte Volck was approved. Birgitte Volck has been
granted 4,674 RSUs in line with the terms set out in the minutes from the Annual
General Meeting.
Further, 200,000 share options have been granted to Mikkel Wandahl Pedersen in
connection with his appointment as Chief Scientific Officer. The share options
will have a strike price of NOK 81.14 per share, have a five-year term and will
vest equally over a four-year vesting period. After the award of the share
options, Mikkel Wandahl Pedersen holds a total of 200,000 share options and 0
shares.
Please see further details in attached document.